VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $315,000 | -92.0% | 525,000 | -49.7% | 0.00% | -90.3% |
| Q1 2018 | $3,915,000 | +27864.3% | 1,043,600 | +406.8% | 0.03% | – |
| Q4 2017 | $14,000 | -97.4% | 205,900 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $535,000 | -78.6% | 205,900 | -58.8% | 0.01% | -72.2% |
| Q1 2016 | $2,500,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pentwater Capital Management LP | 3,770,300 | $75,934,000 | 1.01% |
| SIMPLEX TRADING, LLC | 8,247 | $6,549,000 | 0.44% |
| Thrax Management, LLC | 100,000 | $2,014,000 | 0.31% |
| GROUP ONE TRADING, L.P. | 994,600 | $20,031,000 | 0.24% |
| CMT Asset Management Ltd | 192,800 | $3,883,000 | 0.20% |
| Citadel Advisors | 1,838,900 | $37,035,000 | 0.04% |
| JPMORGAN CHASE & CO | 135,000 | $2,719,000 | 0.00% |